Understanding the role of the mitochondria and HIF-1α in the mechanotransductive pathways driving chronic lymphatic vascular abnormalities could lead to innovative therapeutic strategies for children with congenital heart disease and other disorders of lymphatic function. Here, HIF1A is linked to congenital heart disease.